CAR T access and outcomes in large B‐cell lymphoma according to ethnicity and socioeconomic deprivation in the UK
British Journal of Haematology · 2025
DOI: 10.1111/bjh.19997 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Diana Dragoi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, King's College Hospital, London, UK. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Immunotherapy, Adoptive, Health Services Accessibility, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Data on the impact of ethnic and socioeconomic factors on Chimeric antigen receptor (CAR) T‐cell therapy (access and outcomes are limited, but key to understand whether results from the registration trials are generalizable to real‐world patient populations. Here, we analysed ethnicity, socioeconomic deprivation and referral patterns in a cohort of 314 large B‐cell lymphoma patients approved for third‐line CD19 CAR‐T across three large UK CAR‐T centres. Patients from deprived areas had a lower infusion rate compared to low deprivation areas (73% vs. 86%, p = 0.04). CAR‐T response rates, toxicities, progression‐free survival or non‐relapse mortality were similar with respect to ethnicity or deprivation. We did not find evidence of referral barriers according to ethnicity, but potential regional barriers for socioeconomically deprived patients in two of three centres. Intention‐to‐treat overall survival was significantly inferior in patients from deprived areas (1‐year OS 44.5% vs. 58% for high vs. low deprivation; p = 0.02), likely reflecting general health disparities and higher drop‐out rates in this group. Our data suggest similar outcomes of CD19 CAR‐T‐treated patients across a socioeconomically and ethnically heterogeneous real‐world population. Results demonstrate broad access to CAR‐T within the UK national delivery system, but the high drop‐out rate and potential regional referral barriers for deprived communities should be further investigated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Haematology, King's College Hospital, London, UK.
- Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
- NIHR Blood and Transplant Research Unit (BTRU) in Precision Transplant and Cellular Therapeutics, University of Birmingham, Birmingham, UK.
- Department of Haematology, Manchester Royal Infirmary, Manchester, UK.
- Department of Haematology, Queen Elizabeth Hospital, Birmingham, UK.
- Comprehensive Cancer Centre, King's College London, London, UK.
ORCID-Profile: Diana Dragoi, Robin Sanderson, Emil Kumar, Andrea Kuhnl
Zitieren
APA
Dragoi, D., Cusworth, S., Oldham, L., Sanderson, R., Norman, J., Chandan, J. S., Mathew, A., Kumar, E., Paneesha, S., Tholouli, E., Moya Davila, A., Bouziana, S., Patten, P., Hardefeldt, P., Yallop, D., Chaganti, S., Burns, D., & Kuhnl, A. (2025). CAR T access and outcomes in large B‐cell lymphoma according to ethnicity and socioeconomic deprivation in the UK. British Journal of Haematology. https://doi.org/10.1111/bjh.19997
Vancouver
Dragoi D, Cusworth S, Oldham L, Sanderson R, Norman J, Chandan JS, et al. CAR T access and outcomes in large B‐cell lymphoma according to ethnicity and socioeconomic deprivation in the UK. British Journal of Haematology. 2025. doi:10.1111/bjh.19997
BibTeX
@article{Dragoi2025,
author = {Dragoi, Diana and Cusworth, Samuel and Oldham, Laura and Sanderson, Robin and Norman, Jane and Chandan, Joht Singh and Mathew, Amrith and Kumar, Emil and Paneesha, Shankara and Tholouli, Eleni and Moya Davila, Andres and Bouziana, Styliani and Patten, Piers and Hardefeldt, Prudence and Yallop, Deborah and Chaganti, Sridhar and Burns, David and Kuhnl, Andrea},
title = {CAR T access and outcomes in large B‐cell lymphoma according to ethnicity and socioeconomic deprivation in the UK},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.19997}
}
EUVIMED